Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line
Conclusion Our results suggest that the bach1 can be considered as a potent adjuvant in breast cancer therapy.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
More News: Adenocarcinoma | Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Drugs & Pharmacology | Genetics | Study